Search This Blog

Wednesday, July 8, 2020

Therapeutics Acquisition prices upsized $118M IPO at $10

Therapeutics Acquisition (TXAC) priced its initial public offering (IPO) of 11.8M Class A common shares at $10/share.
Trading commenced today. Shares are currently exchanging hands at $11.39 up 14%.
In June the company filed preliminary prospectus for a $100M offering.

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)